Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Next Science Oral Rinse is a specialized biofilm-disrupting solution designed to reduce the microbial load in the oral cavity, particularly targeting bacteria protected within biofilms. Developed by Next Science, the rinse utilizes the company proprietary Xbio technology, which is engineered to deconstruct the extracellular polymeric substance (EPS) matrix that shields bacteria from traditional antimicrobials and the host immune system. By breaking down this structural matrix, the rinse exposes the underlying microorganisms, facilitating their mechanical removal and destruction. It is primarily indicated for use as a pre-procedural or peri-operative rinse to minimize the risk of surgical site infections (SSIs) in patients undergoing oral, dental, or maxillofacial procedures. Unlike conventional mouthwashes that primarily target planktonic bacteria, this formulation is specifically optimized to address the structural integrity of established biofilms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Next Science Oral Rinse.